COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
pharmaphorum
AUGUST 27, 2020
Regulatory pressures, lengthy drug development times, and the fact that drug prices have become politicised have raised risks and cut revenue projections, leading to the biotech sector falling out of fashion. The first is that the development of vaccines is utilising cutting edge technologies.
94 
Let's personalize your content